Professional Documents
Culture Documents
Skin Tumors
Skin Tumors
Dermoid cysts are congenital lesions that result when epithelium is trapped
during fetal midline closure. Although the eyebrow is the most frequent site of
presentation, dermoid cysts are common anywhere from the nasal tip to the forehead.
Trichilemmal (pilar) cysts, the second most common cutaneous cyst, occur
more often on the scalp of females. When ruptured, these cysts have an intense,
characteristic odor.
Cutaneous horns
Cutaneous horns are elongated, keratinous projections from the skin, ranging
in size from a few millimeters to many centimeters. Because they are suggestive of
underlying anaplasia, biopsy examination is warranted. Most cutaneous horns arise
from actinic keratoses but they may also result from seborrheic keratoses, warts,
keratoacanthomas, squamous cell carcinomas, and basal cell carcinomas.
Total excision of the nevus is the treatment of choice; however, the lesion is
often so large that inadequate tissue for wound closure precludes complete resection.
Instead, serial excisions with local tissue expansion/advancement are frequently
required over several years.
Hemangiomas are benign vascular neoplasms that present soon after birth.
They initially undergo rapid cellular proliferation over the first year of life, then
undergo slow involution throughout childhood. In contrast to neoplasms, vascular
malformations are a result of structural abnormalities formed during fetal
development. Unlike hemangiomas, vascular malformations grow in proportion to the
body and never involute.
Histologically, hemangiomas are composed of mitotically active endothelial
cells surroundings several, confluent blood-filled spaces. Although these lesions may
enlarge significantly in the first year of life, approximately 90% involute over time.
Lipomas are the most common subcutaneous neoplasm. Although they are
found most frequently on the trunk, these lesions may appear anywhere. Typically
soft and fleshy on palpation, lipomas may grow to a large size and become
substantially deforming. Histologic examination reveals a lobulated tumor composed
of normal fat cells. It is not premalignant.
Etiology:
Radiation therapy directed at skin lesions increases the risk for local BCC and
SCC. As an ongoing area of intense research interest, certain subtypes of HPV have
been linked to SCC. Additionally, chronically irritated or nonhealing areas such as
burn scars, sites of repeated bullous skin sloughing, and decubitus ulcers present an
elevated risk of developing SCC. Systemic immunologic dysfunction is also related to
an increase in cutaneous malignancies. Immunosuppressed patients receiving
chemotherapy, those with advanced HIV/AIDS, and immunosuppressed transplant
recipients have an increased incidence of BCC, SCC, and melanoma.
Arising from the basal cell layer of the epidermis, BCC is the most common
type of skin cancer.
superficial spreading,
micronodular,
infiltrative,
pigmented, and
morpheaform.
BCCs are slow growing, and metastasis is extremely rare. Due to this slow
developmental progression, patients often neglect these lesions for years and
presentation with extensive local tissue destruction is common.
Treatment: The majority of small (less than 2 mm), nodular lesions may be
treated via curettage, electrodesiccation, or laser vaporization.
Although effective, these techniques destroy any potential tissue sample for
confirmatory pathology diagnosis and tumor margin analysis. Surgical excision may
be used to both effect complete tumor removal as well as allow proper laboratory
evaluation. Basal cell tumors located at areas of great aesthetic value, such as the
cheek, nose, or lip, may be best approached with Mohs' surgery. Typically completed
by specialized dermatology surgeons, Mohs' surgery uses minimal tissue resection
and immediate microscopic analysis to confirm appropriate resection. Large tumors,
those that invade surrounding structures, and aggressive histologic types
(morpheaform, infiltrative, and basosquamous) are best treated by surgical excision
with 0.5-cm to 1-cm safety margins.
Although basal cell carcinoma is the most common tumor involving the head
and neck, squamous cell carcinoma occurs with high frequency on the nose, ears, and
lower lip.
The need for lymph node (LN) dissection in the setting of SCC remains a topic
of debate. Regional LN excision is indicated for clinically palpable nodes. However,
SCC lesions arising in chronic wounds are more aggressive and regional lymph node
metastases are observed more frequently. In this instance, lymphadenectomy before
development of palpable nodes (prophylactic LN dissection) is indicated. Metastatic
disease is a poor prognostic sign, and only 13% of patients typically survive 10 years.
Basal and squamous cell lesions often present on sun-exposed portions of the
body such as the head and face.
Unfortunately, these areas are of great aesthetic value and significant tissue
loss may significantly alter facial symmetry, contour, and continuity. Developed in
1936, Mohs' technique uses serial excision in small increments coupled with
immediate microscopic analysis to ensure tumor removal, yet limit resection of
aesthetically valuable tissue. One distinct advantage of Mohs' technique is that all
specimen margins are evaluated. In contrast, traditional histologic examination
surveys selected portions on surgical margin. The major benefit of Mohs' technique is
the ability to remove a tumor with minimal sacrifice of uninvolved tissue. Although
this procedure is of particular value when managing tumors of the eyelid, nose, or
cheek, one major drawback is procedure length. Total lesion excision may require
multiple attempts at resection, and many procedures may be carried out over several
days. Recurrence and metastases rates are comparable to those of wide local excision.
Malignant melanoma
Sites: Although the eye and anus are notable sites, over 90% of melanomas
are found on the skin. 4% of tumors are discovered as metastases without any
identifiable primary site. Suspicious features suggestive of malignant transformation
include any pigmented lesion with recent irregular border, darkening coloration,
ulceration, and raised surface. 5 to 10% of melanomas are nonpigmented.
Superficial spreading (70%): anywhere on the skin except the hands and feet.
They are typically flat and measure 1 to 2 cm in diameter at diagnosis.
Nodular (15-30%)
Histologic type
Depth of invasion
Head, neck, or trunk (10-year survival rate of 82% for localized disease of the
extremity compared to a 68% survival rate with a lesion of the face).
Clark histologic level [I, superficial to basement membrane (in situ); II,
papillary dermis; III, papillary/reticular dermal junction; IV, reticular dermis; and V,
subcutaneous fat].
Breslow measured lesions from the granular layer of the epidermis or the base
of the ulcer to the greatest depth of the tumor (I, 0.75 mm or less; II, 0.76 to 1.5 mm;
III, 1.51 to 4.0 mm; IV, 4.0 mm or more).
Treatment
The surrounding tissue should be removed down to the fascia to remove all
lymphatic channels. If the deep fascia is not involved by the tumor, removing it does
not affect recurrence or survival rates, so the fascia is left intact.
Thin lesions (less than 1 mm), the tumor cells are still localized in the
surrounding tissue, and the cure rate is excellent with wide excision of the primary
lesion; therefore treatment of regional LNs is not beneficial.
Lesions deeper than 4 mm, it is highly likely that the tumor cells already have
spread to the regional LNs and distant sites. Removal of the melanomatous LNs has
no effect on survival. Most of these patients die of metastatic disease before
developing problems in regional nodes.
In patients with intermediate-thickness tumors (T2 and T3, 1 to 4.0 mm) and
no clinical evidence of nodal or metastatic disease, the use of prophylactic dissection
(elective LN dissection on clinically negative nodes) is controversial. To date, no
prospective, randomized studies have demonstrated that elective LN dissection
improves survival in patients with intermediate-thickness melanomas. However, 25 to
50% of LN specimens contain micrometastases in these cases and recurrence may be
decreased with LN dissection.
Metasxtasis:
Solitary lesions in the brain, GI tract, or skin that are symptomatic should be
excised when possible. Although cure is extremely rare, the degree of palliation can
be high and asymptomatic survival prolonged
Hyperthermic regional perfusion with a chemotherapeutic agent (e.g.,
melphalan) is presently the treatment of choice. The goal of regional perfusion
therapy is to increase the dosage of the chemotherapeutic agent to maximize tumor
response while limiting systemic toxic effects. Melphalan generally is heated to an
elevated temperature [up to 41.5°C, (106.7°F)] and perfused for 60 to 90 minutes.
Although difficult to perform and associated with complications (neutropenia,
amputation, death), it does produce a high response rate (greater than 50%). The
introduction of tumor necrosis factor alpha or interferon- with melphalan results in the
regression of more than 90% of cutaneous in-transit metastases.
Kaposi's Sarcoma
Kaposi's sarcoma (KS) appears as rubbery bluish nodules that occur primarily
on the extremities but may appear anywhere on the skin and viscera. These lesions are
usually multifocal rather than metastatic. Histologically, the lesions are composed of
capillaries lined by atypical endothelial cells. Early lesions may resemble
hemangiomas, while older lesions contain more spindle cells and resemble sarcomas.
Classically, KS is seen in people of Eastern Europe or sub-Saharan Africa. The
lesions are locally aggressive but undergo periods of remission. A different variety of
KS has been described for people with AIDS or with immunosuppression from
chemotherapy. For reasons not yet understood, AIDS-related KS occurs primarily in
male homosexuals and not in IV drug abusers or hemophiliacs. In this form of the
disease, the lesions spread rapidly to the nodes, and the GI and respiratory tract often
are involved. Development of AIDS-related KS is associated with concurrent
infection with a herpes-like virus. Treatment for all types of KS consists of radiation
to the lesions. Combination chemotherapy is effective in controlling the disease,
although most patients develop an opportunistic infection during or shortly after
treatment. Surgical treatment is reserved for lesions that interfere with vital functions,
such as bowel obstruction or airway compromise.
Angiosarcoma
Angiosarcomas may arise spontaneously, mostly on the scalp, face, and neck.
They usually appear as a bruise that spontaneously bleeds or enlarges without trauma.
Tumors also may arise in areas of prior radiation therapy or in the setting of chronic
lymphedema of the arm, such as after mastectomy (Stewart-Treves syndrome). The
angiosarcomas that arise in these areas of chronic change occur decades later. The
tumors consist of anaplastic endothelial cells surrounding vascular channels. Although
total excision of early lesions can provide occasional cure, the prognosis usually is
poor, with 5-year survival rates of less than 20%. Chemotherapy and radiation therapy
are used for palliation.
Dermatofibrosarcoma Protuberans
Fibrosarcoma
Fibrosarcomas are hard, irregular masses found in the subcutaneous fat. The
fibroblasts appear markedly anaplastic with disorganized growth. If they are not
excised completely, metastases usually develop. The 5-year survival rate after
excision is approximately 60%.
Liposarcoma
Liposarcomas arise in the deep muscle planes, and, rarely, from the
subcutaneous tissue. They occur most commonly on the thigh. An enlarging lipoma
should be excised and inspected to distinguish it from a liposarcoma. Wide excision is
the treatment of choice, with radiation therapy reserved for metastatic disease.
SYNDROMIC SKIN MALIGNANCIES
Diseases linked with BCC include the basal cell nevus (Gorlin's) syndrome
and nevus sebaceus of Jadassohn. Basal cell nevus syndrome is an autosomal
dominant disorder characterized by the growth of hundreds of BCCs during young
adulthood. Palmar and plantar pits are a common physical finding and represent foci
of neoplasms. Treatment is limited to excision of only aggressive and symptomatic
lesions. Nevus sebaceus of Jadassohn is a lesion containing several cutaneous tissue
elements that develops during childhood. This lesion is associated with a variety of
neoplasms of the epidermis, but most commonly BCC.
Diseases associated with SCC may have a causative role in the development
of carcinoma. Skin diseases that cause chronic wounds, such as epidermolysis
bullosus and lupus erythematosus, are associated with a high incidence of SCC.
Epidermodysplasia verruciformis is a rare autosomal recessive disease associated with
infection with HPV. Large verrucous lesions develop early in life and often progress
to invasive SCC in middle age. Xeroderma pigmentosum is an autosomal recessive
disease associated with a defect in cellular repair of DNA damage. The inability of the
skin to correct DNA damage from UV radiation leaves these patients prone to
cutaneous malignancies. SCCs are most frequent, but BCCs, melanomas, and even
acute leukemias are seen.